Recent Updates
Recently added Catalysts
LXRX

Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities

Key Takeaway: Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities
Price reaction · baseline $2.17 (2024-03-08 close) · 1 other LXRX headline(s) in the window, move may be shared
day 0 close · peak
+29.5%
day 1
+16.1%
day 3
+12%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+111%
120-day peak, hindsight
Typical move
11%
average across 13 past catalysts
Cash runway
~61 mo
Minimal dilution risk
Lead asset
Sotagliflozin
Phase 3 · Type 1 Diabetes Mellitus

Full Press Release Details

Lexicon Announces Oversubscribed $250 Million Private Placement of Equity Securities.
Last updated: Mar 11, 2024